Stockreport

Junshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China's Hong Kong SAR [Financial Post (Toronto, Ontario, Canada)]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF SHANGHAI, Oct. 15, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceut [Read more]